Differential Sensitivity of p53(-) and p53(+) Cells to Caffeine-induced Radiosensitization and Override of G2 Delay

Cancer Research

Volumn 55, Issue 8, 1995, Pages 1643-1648

  Powell, Simon N ^a   DeFrank, Jeffrey S ^a   Connell, Paul ^a   Eogan, Maeve ^a   Preffer, Frederic ^a   Dombkowski, David ^a   Tang, Wei ^a   Friend, Stephen ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; PROTEIN P53;

ANIMAL CELL; ARTICLE; CANCER CELL DESTRUCTION; CANCER RADIOTHERAPY; CELL CYCLE G2 PHASE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; FIBROBLAST; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; RAT; TUMOR SUPPRESSOR GENE;

ANIMAL; CAFFEINE; CELL CYCLE; CELL SURVIVAL; CELLS, CULTURED; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, RADIATION; EMBRYO; FIBROBLASTS; G2 PHASE; GENES, P53; MICE; MICE, KNOCKOUT; MITOSIS; RADIATION-SENSITIZING AGENTS; SUPPORT, U.S. GOV'T, P.H.S.; X-RAYS;

EID: 0028936626     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304–6311, 1991.
2. Nelson, W. G., and Kastan, M. B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol., 14: 1815–1823, 1994.
3. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587–597, 1992.
4. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855–4878, 1994.
5. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491–7495, 1992.
6. Mcllwrath, A. J., Vasey, P. A., Ross, G. M., and Brown, R. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res., 54: 3718–3722, 1994.
7. Brachman, D. G., Beckett, M., Graves, D., Haraf, D., Vokes, E., and Weichselbaum, R. R. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res., 53: 3667–3669, 1993.
8. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes [see comments]. Nature (Lond.), 362: 847–849, 1993.
9. O'Connor, P. M., Jackman, J., Jondle, D., Bhatia, K., Magrath, I., and Kohn, K. W. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res., 53: 4776–4780, 1993.
10. Slichenmyer, W. J., Nelson, W. G., Slebos, R. J., and Kastan, M. B. Loss of a p53-associated Gl checkpoint does not decrease cell survival following DNA damage. Cancer Res., 53: 4164–4168, 1993.
11. Andreassen, P. R., and Margolis, R. L. 2-Aminopurine overrides multiple cell cycle checkpoints in BHK cells. Proc. Natl. Acad. Sci. USA, 89: 2272–2276, 1992.
12. Weinert, T. A., and Hartwell, L. H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science (Washington DC), 241: 317–322, 1988.
13. Rowley, R. Reduction of radiation-induced G2 arrest by caffeine. Radiat. Res., 129: 224–227, 1992.
14. Livingstone, L. R., White, A., Sprouse, J., livanos, E., Jacks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 925-935, 1992.
15. Diller, L., Kassel, J., Nelson, C. E., et al p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol., 10: 5772–5781, 1990.
16. Pardo, F. S., Su, M., Borek, C, Preffer, F., Dombkowski, D., Gerweck, L., and Schmidt, E. V. Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiat. Res., 140: 180–185, 1994.
17. Bristow, R. G., Jang, A., Peacock, J., Chung, S., Benchimol, S., and Hill, R. P. Mutant p53 increases radioresistant in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene, 9: 1527–1536, 1994.
18. Taylor, Y. C., Parsian, A. J., and Duncan, P. G. Differential post-irradiation caffeine response in normal diploid versus SV40-transformed human fibroblasts: potential role of nuclear organization and protein-composition. Int. J. Radiat. Biol., 64: 57–70, 1993.
19. Nagasawa, H., Keng, P., Harley, R., Dahlberg, W., and Little, J. B. Relationship between gamma-ray-induced G2/M delay and cellular radiosensitivity. Int. J. Radiat. Biol., 66: 373–379, 1994.
20. Musk, S. R. Reduction of radiation-induced cell cycle blocks by caffeine does not necessarily lead to increased cell killing. Radiat. Res., 125: 262–266, 1991.
21. Harvey, M., Sands, A. T., Weiss, R. S., Hegi, M. E., Wiseman, R. W., Pantazis, P., Tainsky, M. A., Bradley, A., and Donehower, L. A. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene, 8: 2457–2467, 1993.
22. Fan, S., Rivet, D. J., Smith, M. L., Zhan, Q., Kohn, K. W., Fornace, A. J., and O'Connor, P. M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res., 55: 1649–1654, 1995.
23. Russell, K. J., Wiens, L. W., Galloway, D. A., Pion, S. E., and Groudine, M. Abrogation of the G2 checkpoint results in differential radiosensitization of Gl checkpoint-deficient and competent cells. Cancer Res., 55: 1639–1642, 1995.